References
- Forbes I J, Roitt I M, Doniach D, Solomon IL. The thyroid cytoloxic autoantibody. J Clin Invest 1962; 41: 996–1006
- Calder A E, Penhale W J, McLcman D, Barnes E W, Irvine WJ. Lymphocyte-dependent antibody-mediated cytotoxicity in Hashimoto thyroiditis. Clin Exp Immunol 1973; 14: 153–158
- Kite J H, Rose N R, Kano K, Witebsky E. Cytotoxicity of human thyroid autoantibodies. Ann NY Acad Sci 1965; 124: 626–634
- Bogner U, Schleusener H, Wall JR. Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not in Graves' disease. J Clin Endocrinol Metab 1984; 59: 734–738
- Mackenzie W A, Davies TF. An intrathyroidal T-cell clone specifically cytotoxic for human thyroid cells. Immunol 1987; 61: 101–103
- Amino N, Mori H, Iwatani Y, Asari S, Izumiguchi Y, Miyai K. Peripheral K lymphocytes in autoimmune thyroid disease: decrease in Graves' disease and increase in Hashimoto's disease. J Clin Endocrinol Metab 1982; 54: 587–591
- Wall J R, Baur H, Schleusener H, Bandy-Dafoe P. Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies. J Clin Endocrinol Metab 1983; 56: 164–169
- Mariotti S, Chiovato L, Vitti P. Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. Clin Immunol Immunopathol 1989; 50: 573–584
- Bogner U, Wall J R, Schleusener H. Cellular and antibody mediated cytotoxicity in autoimmune thyroid disease. Acta Endocrinol (Copenh) 1987; 281: 133–138
- Sack J, Baker J R, Weetman A P, Wartofsky L, Burman KD. Killer cell activity and antibody-dependent cell mediated cytotoxicity are normal in Hashimoto's disease. J Clin Endocrinol Metah 1986; 62: 1059–1064
- Bogner U, Grüters A, Sigle B, Helge H, Schleusener H. Cytotoxic antibodies in congenital hypothyroidism. J Clin Endocrinol Metab 1989; 68: 671–675
- Hiromatsu Y, Fukazawa H, Guinard F, Salvi M, How J, Wall JR. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy. J Clin Endocrinol Melab 1988; 67: 565–570
- Ciccone E, Pende D, Viale O. Specific recognition of human CD3- CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells. J Exp Med 1990; 172: 47–52
- Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187–376
- Khoury E L, Hammond L, Bottazzo G F, Doniach D. Presence of the organ-specific “microsomal” autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity. Clin Exp Immunol 1981; 45: 316–328
- Lefort G, Lanet M J, Ducassou D, Latapie JL. Dosage des anticorps anti-thyroglobuline par une méthode radioimmunologique utilisant la protéine A staphylococcique comme agent de separation. Pathol Biol 1981; 29: 285–291
- Orgiazzi J, Madec A M, Mornex R. Physiopathological relevance of thyroid stimulating antibody (TSAb) measurements in Graves' disease. Thyroid Autoimmunity, A Pinchera, SH Ingbar, JM McKenzie, GF Fenzi. Plenum Publishing Corporation. 1987; 77–82
- Munari-Silem Y, Mesnil M, Selmi S, Bernier-Valentin F, Rabilloud R, Rousset B. Cell-cell interactions in the process of differentiation of thyroid epithelial cells into follicles: a study by microinjection and fluorescence microscopy on in vitro reconstituted thyroid follicles. J Cellular Physiology 1990; 145: 414–427
- Madec A M, Clavel S, Stefanutti A, Orgiazzi J. Blocking anti-thyrotropin receptor antibodies desensitize cultured human thyroid cells. Endocrinology 1988; 123: 2062–2066
- Solomon D H, Chopra I J, Chopra U, Smith FJ. Identification of subgroups of euthyroid Graves' ophthalmopathy. N Eng J Med 1977; 296: 181–186
- Bastenie P A, Neve P, Bonnyns M, Vanhaelst L, Chailly M. Clinical and pathological significance of asymptomatic atrophic thyroiditis. Lancet 1967; 1: 915–919
- Yoshida H, Amino N, Yagawa K. Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland; studies of seventy autopsied cases. J Clin Endocrinol Metab 1978; 46: 859–862
- Magnusson R P, Chazenbalk G D, Gestautas J. Molecular cloning of the complementary deoxyribonucleic acid for human thyroid peroxidase. Mol Endocrinol 1987; 1: 856–861
- Yokohama N, Taurog A, Klee GG. Thyroid peroxidase and thyroid microsomal autoantibodies. J Clin Endocrinol Metab 1989; 68: 766–773
- Chiovato L, Vitti P, Cucchi P, Mammoli C, Carayon P, Pinchera A. The expression of the microsomall peroxidase autoantigen in human thyroid cells is thyrotropin-dependent. Clin Exp Immunol 1989; 76: 47–53
- Magnusson R P, Rapoport B. Modulation of differentiated function in cultured thyroid cells: thyrotropin control of thyroid peroxidase activity. Endocrinology 1985; 116: 1493–1500
- Leer L M, Cammenga M, Vandervorm E R, Devijlder J JM. Methimazole increases thyroid-specific mRNA concentration in human thyroid cells and FRTL-5 cells. Mol Cell Endocrinol 1991; 78: 221–228
- Isosaki O, Tsushima T, Emoto N. Methimazole regulation of thyroglobulin biosynthesis and gene transcription in rat FRTL-5 thyroid cells. Endocrinology 1991; 128: 3113–3121
- Young J DE. Killing of target cells by lymphocytes: a mechanistic view. Physiol Rev 1989; 69: 250–314
- Weetman A P, Black C M, Cohen S B, Tomlinson R, Banga J P, Reimer CB. Affinity purification of IgG subclasses and the distribution of thyroid autoantibody reactivity in Hashimoto's thyroiditis. Scand J Immunol 1989; 30: 73–82
- Fukazawa H, Sakurada T, Tamura K. The influence of immunosuppressive acidic protein on the activity of peripheral K-lymphocytes in subacute thyroiditis. J Clin Endocrinol Metab 1990; 71: 193–198
- Migita K, Eguchi K, Tezuki H. Cytotoxic activity of interleukin-2 (IL2) activated killer cells toward thyroid epithelial cells. Clin Exp Immunol 1989; 77: 196–201